India Formulations

Alembic has demonstrated a culture of manufacturing excellence since inception. Our portfolio of world-class facilities delivers innovation at scale. We make continuous efforts in enhancing and upgrading these facilities through focused investments and targeted improvements. Skill development of our people is a priority for us. It ensures that our facilities keep producing at the highest levels of efficiency, scale and excellence. Our plants are designed to maintain uncompromised quality, and stringent compliance. Our agile manufacturing processes help meet evolving market demands.

Major manufacturing facilities

6

Formulations facilities
(5 in Gujarat, 1 in Sikkim)

3

APIs manufacturing
facilities (Gujarat)

Location Dosage Form Last USFDA Audit

International Generics

F1 - Panelav

General Oral Solids

March 2020

F2 - Panelav

Oncology Oral Solids


Oncology Injectables

June 2019
October 2022

F3 - Karkhadi

General Injectables Ophthalmic

March 2023

F4 - Jarod

General Oral Solids

December 2022

Derma - Karkhadi

Various derma forms

March 2023

API

API I & II - Panelav

December 2018

API III - Karkhadi

January 2020

All EIRs in place other than F4-Jarod

Manufacturing facilities

USFDA
Approved

F2 - Oncology OSD D

USFDA
Approved

F2 - Oncology injectable

USFDA
Approved

F3 - General Injectable & Ophthalmic

USFDA
Audit completed

F4 - New Oral solids